2798
N. Gommermann et al.
LETTER
N3
O
Acknowledgment
n-Pent
NBn2
O
We thank the Fonds der Chemischen Industrie and Merck Research
Laboratories (MSD) for financial support. We thank the DFG (SPP
1118 ‘Sekundäre Wechselwirkungen als Steuerungsprinzip zur
gerichteten Funktionalisierung reaktionsträger Substrate’) for a
fellowship for N.G. and Chemetall GmbH (Frankfurt) and BASF
AG (Ludwigshafen) for generous gift of chemicals.
Cu0
NBn2
N
N
+
N
O
n-Pent
t-BuOH/H2O
O
OMe
OMe
5k: 88% ee
7b
6k: 52%
n-Pent
NBn2
References
OH
N3
NBn2
Cu0
(1) (a) Joule, J. A.; Mills, K.; Smith, G. F. Heterocyclic
Chemistry; Stanley Thornes Publishers Ltd: Cheltenham,
1998. (b) Wang, Y.; Dong, X.; Larock, R. C. J. Org. Chem.
2003, 68, 3090. (c) Larock, R. C.; Roesch, K. R. J. Org.
Chem. 2002, 67, 86. (d) Larock, R. C.; Pace, P.; Yang, H.;
Russel, C. E. Tetrahedron 1998, 54, 9961. (e) Larock, C.
L.; Yum, E. K.; Doty, M. J.; Sham, K. K. C. J. Org. Chem.
1995, 60, 3270. (f) Larock, R. C.; Yang, H. J. Org. Chem.
1994, 59, 4172. (g) Lindsay, D. M.; Dohle, W.; Jensen, A.
E.; Kopp, F.; Knochel, P. Org. Lett. 2002, 4, 1819.
(2) (a) Huisgen, R. Angew. Chem., Int. Ed. Engl. 1963, 2, 565.
(b) Huisgen, R. In 1,3-Dipolar Cycloaddition Chemistry,
Vol. 1; Padwa, A., Ed.; Wiley: New York, 1984.
N
+
N
N
OH
n-Pr
t-BuOH/H2O
5l: 90% ee
rac-7c
6l: 95%
Scheme 3 Formation of functionalized chiral a-aminotriazoles 6k–l
OMe
OMe
Cu0
N3
+
N
t-BuOH/H2O
N
Ph
N
Br
Br
(3) (a) Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew. Chem.
Int. Ed. 2001, 40, 2004. (b) Kolb, H. C.; Sharpless, K. B.
Drug Discov. Today 2003, 8, 1128.
9: 92%, 99% ee
8: 99% ee
7a
Scheme 4 Synthesis of a-alkoxytriazole 9
(4) (a) Gommermann, N.; Koradin, C.; Polborn, K.; Knochel, P.
Angew. Chem. Int. Ed. 2003, 42, 5763. (b) Gommermann,
N.; Knochel, P. Chem. Commun. 2004, 2324. (c) Dube, H.;
Gommermann, N.; Knochel, P. Synthesis 2004, 2015.
(5) For an excellent review, see: (a) Wei, C. M.; Li, Z.; Li, C.-J.
Synlett 2004, 1472. (b) Wei, C. M.; Li, C.-J. J. Am. Chem.
Soc. 2003, 125, 9584. (c) Akullian, L. C.; Snapper, M. L.;
Hoveyda, A. H. Angew. Chem. Int. Ed. 2003, 42, 4244.
(d) Sakaguchi, S.; Kubo, T.; Ishii, Y. Angew. Chem. Int. Ed.
2001, 40, 2534. (e) Shi, L.; Tu, Y.-Q.; Wang, M.; Zhang, F.-
M.; Fan, C.-A. Org. Lett. 2004, 6, 1001. (f) Wei, C. M.; Li,
C.-J. J. Am. Chem. Soc. 2002, 124, 5638. (g) Wei, C. M.;
Li, Z. G.; Li, C.-J. Org. Lett. 2003, 5, 4473. (h) Li, Z.; Li,
C.-J. Org. Lett. 2004, 6, 4997. (i) Traverse, J. F.; Hoveyda,
A. H.; Snapper, M. L. Org. Lett. 2003, 5, 3273. (j) For the
preparation of chiral propargylic alcohols see: Frantz, D. E.;
Faessler, R.; Carreira, E. M. J. Am. Chem. Soc. 2000, 122,
1806.
(6) (a) Valk, J. M.; Whitlock, G. A.; Layzell, T. P.; Brown, J. M.
Tetrahedron: Asymmetry 1995, 6, 2593. (b) Fernandez, E.;
Maeda, K.; Hooper, M. W.; Brown, J. M. Chem.–Eur. J.
2000, 6, 1840.
(7) (a) Lee, L. V.; Mitchell, M. L.; Huang, S.-J.; Fokin, V. V.;
Sharpless, K. B.; Wong, C.-H. J. Am. Chem. Soc. 2003, 125,
9588. (b) Mocharla, V. P.; Colasson, B.; Lee, L. V.; Röper,
S.; Sharpless, K. B.; Wong, C.-H.; Kolb, H. C. Angew.
Chem. Int. Ed. 2005, 44, 116.
Further applications of this methodology towards the
preparation of natural products and biologically active
compounds are currently underway in our laboratories.
Preparation of (–)-N,N-Dibenzyl-1-(1-benzyl-1H-1,2,3-triazol-
4-yl)-2-ethylbutan-1-amine (6e)
Propargylamine (–)-5e (306 mg, 1.0 mmol)4b was dissolved in t-
BuOH–H2O (2:1, 3 mL) at r.t. Benzyl azide 7a (200 mg, 1.5 mmol)
was added, followed by copper(0) powder (1.0 g). The reaction
mixture was stirred at r.t. for 4 d, diluted with CH2Cl2 and filtered
over a pad of Celite. The filtrate was concentrated and the crude
product was purified by column chromatography (SiO2, pentane–
Et2O 4:1) leading to triazole (–)-6e (389 mg, 0.9 mmol, 89%) as a
colorless solid.
25
1
[a]D –88 (c 0.56, CHCl3); mp 91–93 °C. H NMR (300 MHz,
CDCl3): d = 7.35–7.11 (m, 16 H), 5.31 (d, J = 2.9 Hz, 2 H), 3.81–
3.73 (m, 3 H), 3.11 (d, J = 13.8 Hz, 2 H), 2.14–2.01 (m, 1 H), 1.91–
1.76 (m, 1 H), 1.64–1.43 (m, 2 H), 1.06–0.91 (m, 1 H), 0.90–0.73
(m, 1 H), 0.63 (t, J = 7.5 Hz, 3 H), 0.51 (t, J = 7.5 Hz, 3 H). 13C
NMR (75 MHz, CDCl3): d = 145.3, 140.3, 135.6, 129.5, 129.4,
129.0, 128.6, 128.1, 127.1, 122.9, 56.8, 54.7, 54.4, 40.4, 22.1, 20.4,
10.5, 9.5. IR (KBr): 2963, 2936, 1495, 1454, 747, 727, 699 cm–1.
MS (EI, 70 eV): m/z (%) = 438 (<1) [M+], 368 (24), 367 (100), 91
(63). HRMS (EI, 70 eV): m/z calcd for C29H34N4: 438.2783; found:
438.2788.
(8) Alvarez, S. G.; Alvarez, M. T. Synthesis 1997, 413.
(9) Swift, G.; Swern, D. J. Org. Chem. 1967, 32, 511.
Synlett 2005, No. 18, 2796–2798 © Thieme Stuttgart · New York